Trademark Overview
On Friday, February 20, 2026, a trademark application was filed for AQUACYS with the United States Patent and Trademark Office. The USPTO has given the AQUACYS trademark a serial number of 99663191. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Friday, June 12, 2026. This trademark is owned by Aarvik Therapeutics, Inc.. The AQUACYS trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:
Antibody technology platform incorporating engineered cysteines for use in conjugating cysteine reactive small and large molecules, for medical diagnosis and treatment purposes; Antibody technology platform incorporating engineered cysteines for use in conjugating cysteine reactive small and large molecules, resulting in conjugates with improved hydrophilicity, for medical diagnosis and treatment purposes; Antibody technology platform used to incorporate cysteines into an antibody, namely protein arrays, for medical diagnosis and treatment purposes; Delivery devices for antibodies, namely, drug delivery agents in the form of antibody conjugates that facilitate the delivery and action of medical preparations; Antibody products, namely, antibody conjugates for medical diagnosis and treatment in the fields of cancer, inflammatory disease, infectious disease and neurologic diseases and disorders; Chemical, biological and biochemical products for medical and pharmaceutical use, namely, anti...
Research and development of antibody conjugates; Scientific research for medical purposes in the field of cancer, inflammatory disease, infectious disease and neurologic diseases and disorders; Research and development services in the field of antibodies; Scientific and technological services and research relating thereto, namely, scientific research, analysis and testing in the fields of antibody conjugates; Antibody engineering; Custom design and engineering of antibodies; Research and development of pharmaceuticals for the treatment of cancer, inflammatory disease, infectious disease and neurologic diseases and disorders; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Research, development and establishment of testing specifications and procedures in the fields of cancer, inflammatory disease, infectious disease and neurologic diseases and disorders research, diagnosis and treatment; Providing scientific research info...
Antibodies and antibody conjugates for scientific purposes, other than for medical or veterinary purposes; Antibody conjugates for use in the formation of nanoparticles, for scientific and medical research; Chemical substances for the formation of antibody conjugates for use in scientific and medical research; Diagnostic products for scientific and medical research use in the field of antibody conjugates for scientific and medical research; Antibody conjugate technology platform used to incorporate cysteines into an antibody, namely, protein arrays and nucleotide arrays for scientific and medical research; Antibody technology platform incorporating engineered cysteines for use in conjugating cysteine reactive small and large molecules, resulting in conjugates with improved hydrophilicity, for scientific and medical research; Antibody technology platform incorporating engineered cysteines for use in conjugating cysteine reactive small and large molecules, for scientific and medical rese...
